Iowa MedicaidIn Iowa, reimbursement for generic prescription drugs is determined as the lowest of the following methods: the average actual acquisition cost (AAC) plus a professional dispensing fee, the maximum allowable cost (MAC)/federal upper limit (FUL) plus the professional dispensing fee, or the provider's usual and customary charge. In such cases when an AAC rate hasn’t been established, the default reimbursement rate utilizes the Wholesale Acquisition Cost (WAC) rate.
A biennial cost of dispensing (COD) survey of Iowa pharmacies is used to determine the dispensing fee or how much it costs for a pharmacy to fill a prescription excluding the cost of the drug itself. Together, the AAC and COD assist in determining an accurate reimbursement rate for Iowa pharmacies. The dispensing fee is payable once per fill with a maximum of once per month. More information on the dispensing fee can be found here.
AAC Rate Review
Providers that feel the established AAC rate is not accurate may file a rate review with Myers and Stauffer:
Contacting Myers and Stauffer LC
Providers can contact the pharmacy unit of Myers and Stauffer via one of the following:
Regular Mail: Myers and Stauffer LC
9265 Counselors Row, Suite 100
Indianapolis, IN 46240
Phone: (800) 591-1183
Fax: (317) 571-8481
Federal Upper Limit (FUL) Rate Override
IPA worked with Medicaid to compile a list of medications when Medicaid will not apply the FUL to a drug. This override would occur if: (1) the product does not meet the criteria for establishment of a federal upper limit, pursuant to section 1927(e)(4) of the Social Security Act (three or more therapeutically and pharmaceutically equivalent products), or the amount of the FUL is now below 150 percent of the published price for the least costly therapeutic equivalent, and (2) the current FUL is less than the Iowa average AAC. The FUL Override List can be used to identify past claims to be back dated to the effective date; and therefore reimbursed at AAC. Pharmacy professionals should contact the Myers and Stauffer Help Desk at 800-591-1183 to request that the Iowa Medicaid Enterprise review the AAC and FUL for particular drugs.
Preferred Drug List (PDL) Updates
When a status change occurs for a previously preferred brand name drug to non-preferred status, up to a minimum of 30 days transition period is given to pharmacies to help utilize existing brand name product in stock in an effort to decrease a pharmacy’s remaining brand name drug inventory (see PDL comment section regarding transition periods exceeding 30 days). If additional stock remains beyond this time period, pharmacies may call the POS Helpdesk at 877-463-7671 or 515-256-4608 (local) to request an override for the non-preferred brand name drug with a recent status change.
Commercial InsurancePrior to filing a reimbursement-related PBM complaint to the Iowa Insurance Division (IID), pharmacy professionals must first submit a rate review request to the PBM. This process will likely need the assistance of a pharmacy’s contracted PSAO (Pharmacy Services Administrative Organization).
PBM Complaint Process
Following any inadequate rate reimbursement of review with the PBM, a complaint can be submitted to IID with this form.
Other Resources:Pharmacy Audit Assistance Service (PAAS): PAAS is a program developed to assist pharmacists with third-party audits, negotiations and contracts.
*Note – Pharmacy pricing data is confidential and may not be shared with the Iowa Pharmacy Association (IPA) or between IPA members. This information can be used by pharmacies in communicating with their PSAO, the PBM, or the Iowa Insurance Division. Do NOT send or share pharmacy pricing information with the Iowa Pharmacy Association, as it could be a violation of federal anti-trust laws.